Biologics in eosinophilic esophagitis
Purpose of review
Eosinophilic esophagitis (EoE) is a chronic inflammatory disease of the oesophagus whose incidence is on the rise. Despite maximal use of guideline-based therapies including food elimination diets and steroids, many patients remain symptomatic. This review serves to summarize safety and efficacy of monoclonal antibodies in treatment of EoE.
Recent findings
There has been an increasing number of biologics under consideration for EoE and several that have undergone clinical trials. mAbs that target specific effectors involved in the disease may offer additional clinical and histologic benefit. In addition, they offer a more benign adverse effect profile than traditional therapies.
Summary
Biologics for treatment of EoE may result in symptom and histologic improvement and has the potential to treat disease with minimal side effects.
Source: Current Opinion in Allergy and Clinical Immunology - Category: Allergy & Immunology Tags: FOOD ALLERGY: Edited by Alessandro Fiocchi and Motohiro Ebisawa Source Type: research
More News: Allergy | Allergy & Immunology | Clinical Trials | Diets | Food Allergy | Nutrition | Oesophagus